{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:50:49Z","timestamp":1792651849805,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ebiom.2024.105170","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T01:40:55Z","timestamp":1717206055000},"page":"105170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics"],"prefix":"10.1016","volume":"104","author":[{"given":"Ha-Na","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Lewkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaliroi","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Kelley-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian L.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D.C.","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kielczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Fariss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes M.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kyratsous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-8049","authenticated-orcid":false,"given":"Chi-Chao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-9352","authenticated-orcid":false,"given":"Mohanraj","family":"Manangeeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-3071","authenticated-orcid":false,"given":"Daniela","family":"Verthelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2024.105170_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1213\/ANE.0000000000000866","article-title":"Ebola virus disease: a review of its past and present","volume":"121","author":"Murray","year":"2015","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib2","first-page":"81","article-title":"An overview of Ebola virus disease","volume":"2","author":"Kadanali","year":"2015","journal-title":"North Clin Istanb"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011077","article-title":"Ebola virus disrupts the inner blood-retinal barrier by induction of vascular endothelial growth factor in pericytes","volume":"19","author":"Gao","year":"2023","journal-title":"PLoS Pathog"},{"issue":"9768","key":"10.1016\/j.ebiom.2024.105170_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","article-title":"Ebola virus disease and critical illness","volume":"20","author":"Leligdowicz","year":"2016","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105170_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1473-3099(15)00259-5","article-title":"Post-Ebola syndrome","volume":"16","author":"Burki","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105170_bib7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciw158","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105170_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajo.2017.05.029","article-title":"Ocular complications in survivors of the ebola outbreak in Guinea REPLY","volume":"181","author":"Hebert","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32216","article-title":"Characterization of ebola virus-associated eye disease","volume":"4","author":"Eghrari","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2024.105170_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101483","article-title":"Ophthalmic sequelae and psychosocial impact in pediatric ebola survivors","volume":"49","author":"Shantha","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105170_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17469899.2019.1623025","article-title":"Ocular complications in Ebola virus disease survivors: the importance of continuing care in West Africa","volume":"14","author":"Berry","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"issue":"25","key":"10.1016\/j.ebiom.2024.105170_bib12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s42003-022-04158-2","article-title":"Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey","volume":"5","author":"Worwa","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ebiom.2024.105170_bib14","doi-asserted-by":"crossref","first-page":"1083429","DOI":"10.3389\/fphar.2023.1083429","article-title":"Ebanga (TM): the most recent FDA-approved drug for treating Ebola","volume":"14","author":"Taki","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105170_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2023.01.002","article-title":"Structure of the Inmazeb cocktail and resistance to Ebola virus escape","volume":"31","author":"Rayaprolu","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105170_bib16","doi-asserted-by":"crossref","first-page":"E231","DOI":"10.1016\/S1473-3099(20)30282-6","article-title":"Recent successes in therapeutics for Ebola virus disease: no time for complacency","volume":"20","author":"Iversen","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105170_bib17","first-page":"22","article-title":"Monoclonal antibody approved to treat ebola","volume":"121","author":"Aschenbrenner","year":"2021","journal-title":"Am J Nurs"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105170_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/13543784.2021.1881061","article-title":"Targeting Ebola virus replication through pharmaceutical intervention","volume":"30","author":"Hansen","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"issue":"631","key":"10.1016\/j.ebiom.2024.105170_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi5229","article-title":"Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors","volume":"14","author":"Liu","year":"2022","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105170_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/pathogens10101330","article-title":"Structural and functional aspects of ebola virus proteins","volume":"10","author":"Jain","year":"2021","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105170_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib22","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/22221751.2021.1997075","article-title":"Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVDeltaG-EBOV-GP infection model","volume":"10","author":"Lee","year":"2021","journal-title":"Emerg Microb Infect"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105170_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/v12090923","article-title":"A\u00a0surrogate animal model for screening of ebola and marburg glycoprotein-targeting drugs using pseudotyped vesicular stomatitis viruses","volume":"12","author":"Saito","year":"2020","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105170_bib24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.celrep.2019.01.069","article-title":"Pseudovirus rVSVDeltaG-ZEBOV-GP infects neurons in retina and CNS, causing apoptosis and neurodegeneration in neonatal mice","volume":"26","author":"McWilliams","year":"2019","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105170_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006004","article-title":"Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl\/6 mice","volume":"12","author":"Manangeeswaran","year":"2016","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105170_bib26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","article-title":"A\u00a0new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens","volume":"140","author":"Caspi","year":"1988","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105170_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jviromet.2007.02.007","article-title":"Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag","volume":"143","author":"Coleman","year":"2007","journal-title":"J\u00a0Virol Methods"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105170_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006397","article-title":"Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection","volume":"13","author":"Iampietro","year":"2017","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105170_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/ICU.0000000000000426","article-title":"An update on ocular complications of Ebola virus disease","volume":"28","author":"Shantha","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"24","key":"10.1016\/j.ebiom.2024.105170_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00833-21","article-title":"Dose-dependent response to infection with ebola virus in the ferret model and evidence of viral evolution in the eye","volume":"95","author":"Watson","year":"2021","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105170_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.113","article-title":"Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys","volume":"2","author":"Zeng","year":"2017","journal-title":"Nat Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105170_bib32","first-page":"488","article-title":"Vesicular stomatitis virus (VSV) infection in rabbit eye: role of antibody and interferon","volume":"8","author":"Pollikoff","year":"1969","journal-title":"Invest Ophthalmol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105170_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008689","article-title":"Long-term persistence of infectious Zika virus: inflammation and behavioral sequela in mice","volume":"16","author":"Ireland","year":"2020","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105170_bib34","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105170_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105170_bib36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/1744666X.2014.942288","article-title":"Immune responses in neonates","volume":"10","author":"Basha","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105170_bib37","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1113\/JP274938","article-title":"The myth of the immature barrier systems in the developing brain: role in perinatal brain injury","volume":"596","author":"Mallard","year":"2018","journal-title":"J\u00a0Physiol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105170_bib38","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1194\/jlr.D028233","article-title":"Analysis of bioactive oxysterols in newborn mouse brain by LC\/MS","volume":"53","author":"Meljon","year":"2012","journal-title":"J\u00a0Lipid Res"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105170_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fernandez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"Suppl 7","key":"10.1016\/j.ebiom.2024.105170_bib40","doi-asserted-by":"crossref","first-page":"S626","DOI":"10.1093\/infdis\/jiad239","article-title":"Ebola virus tropism in ex\u00a0vivo cynomolgus macaque ocular tissues","volume":"228","author":"Matson","year":"2023","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105170_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.6.4.12","article-title":"Retinal pigment epithelial cells are a potential reservoir for ebola virus in the human eye","volume":"6","author":"Smith","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105170_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008068","article-title":"Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection","volume":"15","author":"Younan","year":"2019","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105170_bib43","doi-asserted-by":"crossref","first-page":"e00845","DOI":"10.1128\/mBio.00845-17","article-title":"Ebola virus binding to tim-1 on T lymphocytes induces a cytokine storm","volume":"8","author":"Younan","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2024.105170_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1023557","article-title":"Macrophage infection, activation, and histopathological findings in ebolavirus infection","volume":"12","author":"Wanninger","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105170_bib45","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(16)00077-3","article-title":"Sequelae of Ebola virus disease: the emergency within the emergency","volume":"16","author":"Vetter","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T13:21:21Z","timestamp":1718544081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424002056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":45,"alternative-id":["S2352396424002056"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105170","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105170"}}